Company Profiles

driven by the PitchBook Platform

Amphivena Therapeutics

Description

Developer of therapeutic antibodies for the treatment of cancer and other diseases. The develops therapy that harnesses the patient’s own immune system to destroy tumor cells and their precursors by allowing the antibodies to bind to target molecules on the surface of tumor cells, T-cells or NK-cells, leading to the breakdown of the cells.

2012

Founded

PRIVATE

Status

1-10

Employees

Series A

Latest Deal Type

$14M

Latest Deal Amount

$14M

Total Amount Raised

Description

Developer of therapeutic antibodies for the treatment of cancer and other diseases. The develops therapy that harnesses the patient’s own immune system to destroy tumor cells and their precursors by allowing the antibodies to bind to target molecules on the surface of tumor cells, T-cells or NK-cells, leading to the breakdown of the cells.

Website:

www.amphivena.com

Formerly Known As

Affimed Spinco

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

45 Juniper Street San Francisco, CA 94103United States
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Amphivena Therapeutics's full profile, request a free trial.

Amphivena Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Amphivena Therapeutics Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Affimed TherapeuticsCorporationMinority000 0000000 0000
Calibrium (Pfäffikon)Family OfficeMinority000 0000000 0000
MPM CapitalVenture CapitalMinority000 0000000 0000
Affimed Therapeutics Corporation
Calibrium (Pfäffikon) Family Office
MPM Capital Venture Capital

Amphivena Therapeutics Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Jeanmarie Guenot Ph.DPresident, Chief Executive Officer and Board Member
Judith Fox Ph.DSenior Vice President, Research & Development
Jeanmarie Guenot Ph.D President, Chief Executive Officer and Board Member
Judith Fox Ph.D Senior Vice President, Research & Development

Amphivena Therapeutics Board Members (4)

NameRepresentingRoleSinceContact
Info
Adi Hoess MDAffimed TherapeuticsChief Executive Officer000 0000
Florian Fischer Ph.DAffimed TherapeuticsChief Financial Officer000 0000
Lori Kunkel MDSelfClinical Advisor & Board Member000 0000
Luke Evnin Ph.DMPM CapitalCo-Founder & Managing Director000 0000
Adi Hoess MD Chief Executive Officer Affimed Therapeutics
Florian Fischer Ph.D Chief Financial Officer Affimed Therapeutics
Lori Kunkel MD Clinical Advisor & Board Member Self
Luke Evnin Ph.D Co-Founder & Managing Director MPM Capital
Request full access to PitchBook